Adagene - Stock Price History | ADAG

Historical daily share price chart and data for Adagene since 2021 adjusted for splits. The latest closing stock price for Adagene as of September 24, 2021 is 14.21.
  • The all-time high Adagene stock closing price was 29.99 on February 09, 2021.
  • The Adagene 52-week high stock price is 31.83, which is 124% above the current share price.
  • The Adagene 52-week low stock price is 11.11, which is 21.8% below the current share price.
  • The average Adagene stock price for the last 52 weeks is 16.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Adagene Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.627B $0.001B
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene Inc. is based in SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71